IPM provides an innovative, integrated genomic and translational research hub for groundbreaking research to redefine complex diseases on a molecular level. Our programs enable Mount Sinai researchers to define genetic risk, molecular pathogenesis and molecular diagnosis of common, complex diseases in unique and well-characterized patient populations that are accessible for studies through a rich fabric of outstanding disease research centers at Mount Sinai.

IPM has initiated several programs to support its mission. The most significant is Biobank, which was established to collect DNA and plasma samples, linked in a de-identified manner to clinical data and information, through routine blood sampling from patients. Core Labs develop and provide critical technologies necessary for in-depth and large-scale genome analysis. The Informatics Program conducts research that makes clinical information systems "research aware" by providing knowledge representation, data integration and data mining algorithms in interdisciplinary research to translational genomics investigators at Mount Sinai.